Enveda Gains Backing from Sanofi to Advance AI-Driven Drug Discovery to Clinical Trials Bringing Total Series C Financing to $150M

BOULDER, Colo.–(BUSINESS WIRE)– #AI–Sanofi invests in Enveda, reaffirming the industry’s confidence in its AI drug discovery platform and ability to deliver differentiated medicines.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks